AMP News 112.34 05/05/2014 04:25:09 Ameriprise Financial Services

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ameriprise Financial Services (AMP) 112.34 $AMP

Quarterly Earnings Releases, Awards, Completion of Project, and Joint Ventures - Analyst Notes on Bradesco, Ameriprise, Huntington, Simon and HCP
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Banco Bradesco SA (NYSE: BBD), Ameriprise Financial Inc. (NYSE: AMP), Huntington Bancshares Incorporated (NASDAQ: HBAN), Simon Property Group Inc. (NYSE: SPG) and HCP Inc. (NYSE: HCP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1974-100free.

Lazard Earnings Beat Ests, Revs Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 3:20PM CDT
Driven by top-line growth, Lazard Ltd.'s (LAZ) first-quarter 2014 adjusted earnings came in at 61 cents per share, easily beating the Zacks Consensus Estimate of 55 cents. Moreover, this compares favorably with 28 cents earned in the prior-year quarter.

Invesco Beats on Q1 Earnings, Hikes Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 12:58PM CDT
Driven by impressive top-line growth, Invesco (IVZ) reported first-quarter 2014 adjusted earnings of 60 cents per share, which beat the Zacks Consensus Estimate of 55 cents. Additionally, this was up 20.0% from the prior-year quarter figure of 50 cents.

Legg Mason Fiscal Q4 Earnings Miss, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 10:16AM CDT
Legg Mason Inc.'s (LM) fiscal fourth-quarter 2014 adjusted earnings came in at 86 cents per share, missing the Zacks Consensus Estimate by 3 cents.

Top Gainers at a Glance -- Research on Ameriprise Financial, Endeavour Silver, Celldex Therapeutics, and Buffalo Wild Wings
PR Newswire - Thu May 01, 3:20AM CDT
The US markets saw a positive sentiment on Tuesday, April 29, 2014, with the NASDAQ Composite closing at 4,103.54, up 0.72%, the Dow Jones Industrial Average ending the session at 16,535.37, up 0.53% and the S&P 500 finishing 0.48% higher at 1,878.33. The gains were broad based as eight out of ten sectors finished on a positive note. A number of stocks saw large movements, including Ameriprise Financial Inc. (NYSE: AMP), Endeavour Silver Corp. (NYSE: EXK), Celldex Therapeutics Inc. (NASDAQ: CLDX) and Buffalo Wild Wings Inc. (NASDAQ: BWLD). Free technical research on AMP, EXK, CLDX and BWLD can be downloaded upon signing up at:

Columbia Management Launches Mortgage Opportunities Fund
Business Wire - Wed Apr 30, 11:07AM CDT
Columbia Management today announced the launch of the Columbia Mortgage Opportunities Fund (CLMZX), an open-end fund which will invest across a full range of mortgage-related and other structured securities. The fund is managed by Jason Callan, head of structured assets, and Tom Heuer, portfolio manager for structured assets.

Affiliated Managers Rises on Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 9:30AM CDT
Shares of Affiliated Managers (AMG) gained nearly 8.5% after it announced first-quarter 2014 ENI of $2.48 per share, which easily beat the Zacks Consensus Estimate of $2.37

Waddell & Reed Beats Q1 Earnings on Higher Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 9:10AM CDT
Strong performance owing to consistent inflows across all the segments drove Waddell & Reed Financial Inc.'s (WDR) first-quarter 2014 earnings per share of 88 cents, which outpaced the Zacks Consensus Estimate of 85 cents.

Stock Market News for April 30, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 9:06AM CDT
Upbeat earnings results and gains in high-growth stocks helped benchmarks close in the green on Tuesday

Watch for Ameriprise Financial to Potentially Pullback After Gaining 5.84% Yesterday
Comtex SmarTrend(R) - Tue Apr 29, 4:15PM CDT
Ameriprise Financial (NYSE:AMP) traded in a range yesterday that spanned from a low of $106.98 to a high of $109.91. Yesterday, the shares gained 5.8%, which took the trading range above the 3-day high of $107.25 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of Ameriprise Financial to Potentially Pullback after Yesterday's 5.84% Rise
Comtex SmarTrend(R) - Tue Apr 29, 4:15PM CDT
Ameriprise Financial (NYSE:AMP) traded in a range yesterday that spanned from a low of $106.98 to a high of $109.91. Yesterday, the shares gained 5.8%, which took the trading range above the 3-day high of $107.25 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Ameriprise Beats on Q1 Earnings, Hikes Div - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 8:40AM CDT
Keeping alive its earnings streak of 2013, Ameriprise Financial Inc. (AMP) reported first-quarter 2014 operating earnings per share of $2.04, which handily surpassed the Zacks Consensus Estimate of $1.87.

Ameriprise Financial declares additional stock buy back programme for USD2.5bn and 12% higher dividend of USD0.58 per share
M2 - Tue Apr 29, 7:04AM CDT
The board of directors of Ameriprise Financial Inc (NYSE:AMP), a provider of financial products and services, approved an additional repurchase of USD2.5bn of its common stock till 28 April 2016, the company said on Tuesday.

Ameriprise Financial Announces Additional $2.5 billion Share Repurchase Program and Increases Regular Quarterly Dividend 12 Percent to $0.58 Per Share
M2 - Tue Apr 29, 3:17AM CDT
The Board of Directors of Ameriprise Financial, Inc. (NYSE: AMP) has authorized an additional $2.5 billion for the repurchase of shares of its common stock through April 28, 2016.

Why Ameriprise Financial (AMP) Stock Is Gaining
at The Street - Mon Apr 28, 3:17PM CDT
Ameriprise Financial (AMP) stock is gaining after the company beat analysts' expectations for earnings in the first quarter.

Ameriprise Financial Reports First Quarter 2014 Results
Business Wire - Mon Apr 28, 3:05PM CDT
--First quarter 2014 return on equity excluding AOCI was 18.2 percent, operating ROE increased 440 bps to a record 20.8 percent

Can Ameriprise (AMP) Keep the Earnings Streak Alive? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 5:50PM CDT
Ameriprise Financial, Inc. (AMP) is scheduled to release first-quarter 2014 results Monday, Apr 28, after market close. Can Ameriprise maintain its earnings streak this quarter? Or will it disappoint?

Earnings Release Dates For Next Week -- Research on Ameriprise Financial, Plum Creek Timber, Sprint, and MGM Resorts Intl.
PR Newswire - Fri Apr 25, 1:24PM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Ameriprise Financial Inc. (NYSE: AMP), Plum Creek Timber Co. Inc. (NYSE: PCL), Sprint Corp. (NYSE: S) and MGM Resorts International (NYSE: MGM). Full earnings notes on AMP, PCL, S and MGM can be downloaded upon signing up at:

T. Rowe Price Beats Earnings, Posts Higher Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 1:06PM CDT
Driven by strong top-line performance, T. Rowe Price Group, Inc. (TROW) reported its first-quarter 2014 net income of $1.05 per share, beating the Zacks Consensus Estimate by 3 cents. Moreover, this significantly outperformed the year-ago earnings of 91 cents.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KROMATID Joins CIRM's Genomic Analysis Initiative

Updated Category News Views 6

New Partnership Opens Doors for Genomic Mastery In a world where biotechnology races to meet the needs of modern medicine, KROMATID's recent nod as an Industry Resource Partnership (IRP) member, courtesy of the California Institute for Regenerative Medicine (CIRM), makes some noise worth noting. This membership isn't just a feather in their cap—it's their ticket to...

Continue Reading
U.S.-Saudi Business Leaders Eye Growth Amid Challenges

Updated Category News Views 85

Revitalizing a Strategic Partnership Monday's meeting of the U.S.-Saudi Business Council wasn't just another gathering of suits; it was about re-kindling the investment flame between these two economic giants. Chaired by powerhouses Lubna Olayan and Jane Fraser, this wasn't a mere photo op. It was a call to arms in a landscape riddled with hurdles but bursting with...

Continue Reading
Lufax's Q3 Struggles: Rising Losses Amid Income Drop

Updated Category News Views 63

Noteworthy Changes in Lufax's Financial Landscape Diving into Lufax's third quarter of 2026, it's clear as day that the numbers are drawing a grim picture. Lufax, a heavyweight in financial services for small business owners in China, announced unflattering financial results. The headline here? A net loss of RMB1,494 million, far from the RMB380 million lost the previous...

Continue Reading
Steel Vet Shift: John Pritchett Takes Helm at Trojan

Updated Category News Views 87

Trojan Steel's Bold Move with John Pritchett at the Helm Trojan Steel is changing the game by appointing John C. Pritchett as its new President. This isn't just another shuffle of suits in the boardroom—it's a statement. Pritchett isn't some steel industry old-timer; instead, he's a business leader with a knack for scaling operations. With a resume that includes...

Continue Reading
Doximity Lawsuit: What Investors Need to Know Now

Updated Category News Views 56

Lawsuit Clouds Hang Over Doximity The courtroom isn't typically where you find stocks making headlines, but Doximity's recent plunge isn't just a market hiccup. After a rough patch, an alleged misstep lands them squarely under the legal microscope, and investors have questions. Tracing Doximity's Rocky Financial Reports First, let's rewind to November last year. Doximity...

Continue Reading
Globe Life Faces Investor Scrutiny Over Leadership

Updated Category News Views 21

Shareholders Put Globe Life Under the Microscope There's something cooking at Globe Life Inc., and it isn't a savory stew of shareholder satisfaction. See, when an investor rights firm like Halper Sadeh LLC starts poking around, suspecting a breach of fiduciary duty by the folks at the top, you know there's some smoke. Questions are looming over whether some brass at...

Continue Reading
Shorenstein Grabs Prime SoHo Office Spot in Big Play

Updated Category News Views 23

Shifting Gears with Shorenstein's Latest Move Sometimes the real estate market feels like a high-stakes poker game, and right now, Shorenstein's just slapped down a winning hand with their acquisition of 148 Lafayette Street in Manhattan's iconic SoHo. No, this isn't just another polished press release about some glass tower. This is about strategic positioning at its...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Celebrating Leaders Advancing Type 1 Diabetes Research

Updated Category News Views 47

Honoring Trailblazers in Type 1 Diabetes Research It's not every day that we get to shine a spotlight on the unsung heroes in the field of Type 1 Diabetes (T1D) research. Today, we pause to celebrate those who are doing the heavy lifting to make the lives of millions better. Breakthrough T1D, the name says it all, presented its prestigious awards to four titans of...

Continue Reading
Home EV Charging Demands Better Electrical Solutions

Updated Category News Views 10

Power Plays in the Dallas Electrical Scene There's a new wrinkle for folks in Dallas slapping Level 2 EV chargers onto their garages. Seems like the plug-in station ain’t the only piece of the puzzle, and Safe Plug Electric is pointing its flashlight at a less obvious snag—electrical capacity. They're preaching from Garland to any soul across Dallas and Collin County...

Continue Reading

Top 5 Most Recently Viewed Articles

Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Updated Category News Views 12

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Continue Reading
Warner Bros. Discovery Evaluates Paramount Skydance Offer

Updated Category News Views 115

Warner Bros. Discovery Evaluates Recent Tender Offer Warner Bros. Discovery, Inc. (NASDAQ: WBD) has recently acknowledged the receipt of an unsolicited, amended tender offer from Paramount Skydance Corporation (NASDAQ: PSKY). This development marks an important moment in the ongoing corporate dynamics of the entertainment industry. Understanding the Amended Tender Offer...

Continue Reading
Kruiz Expands Hope for Pet Travel with Android Launch

Updated Category News Views 254

Kruiz Expands Hope for Pet Travel with Android Launch In a remarkable step forward, Kruiz—an innovative AI-powered travel assistant for pet owners—is officially launching on Android. This announcement comes after its successful debut on iOS, where it quickly gained popularity among pet travelers. Co-founders Brad Pauer and Angela Le recognized the challenges many pet...

Continue Reading
Projected Growth of Castrate-Resistant Prostate Cancer Market

Updated Category News Views 218

Market Overview of Castrate-Resistant Prostate Cancer The castrate-resistant prostate cancer (CRPC) market is set to witness substantial growth in the coming years. With an impressive compound annual growth rate (CAGR) of 8.7% from 2025 to 2034, the market is projected to increase from USD 14.04 billion in 2025 to reach approximately USD 29.79 billion by 2034. The market...

Continue Reading
Discover the Unique Culinary Experience at Drunken Fish

Updated Category News Views 237

Wynn Macau launched its latest dining venture, Drunken Fish, back in 2024 to spice up the culinary scene. This place isn't your average seafood joint; it’s a wild blend of gastronomy and entertainment designed to lure in diners looking for something beyond just a meal. As trends evolve, this new spot grabs attention not just for its food but for the immersive experience...

Continue Reading